Skip to main content
XAIR
NASDAQ Industrial Applications And Services

Beyond Air Seeks Second Reverse Stock Split to Avoid Nasdaq Delisting, Warns of Total Investment Loss

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.515
Mkt Cap
$5.37M
52W Low
$0.43
52W High
$5.842
52W Position info
20% above low
Off High info
91% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

XAIR sits 20% above its 52-week low of $0.43.

Summary

Beyond Air, Inc. proposes a reverse stock split (1:2 to 1:20) to regain Nasdaq compliance after a delisting notice and a prior 1:20 split in July 2025. The company warns that delisting could lead to restructuring and a total loss for stockholders.


Key Events · Corporate Governance and Compliance · XAIR

  • Proposed Reverse Stock Split

    Shareholders will vote on a reverse stock split with a ratio between 1-for-2 and 1-for-20 to increase the stock price and meet Nasdaq's minimum bid price requirement.

  • Nasdaq Delisting Threat

    The company faces delisting from Nasdaq for failing to meet the $1.00 minimum bid price, with a hearing scheduled for May 14, 2026, following a delisting notice on April 7, 2026.

  • Ineligibility for Compliance Period

    Beyond Air is not eligible for a standard compliance period due to a previous 1-for-20 reverse stock split effected on July 14, 2025.

  • Warning of Restructuring Risk

    The company explicitly states that delisting could lead to an inability to raise capital, potential restructuring, and a total loss of investment for stockholders.


Analysis · XAIR · Industrial Applications And Services

This preliminary proxy statement reveals Beyond Air's urgent attempt to avoid delisting from Nasdaq by proposing a second reverse stock split within a year. The company received a delisting notice on April 7, 2026, and is ineligible for a standard compliance period due to a prior 1-for-20 reverse split in July 2025, as previously disclosed in an 8-K on April 15, 2026. A hearing with the Nasdaq Hearings Panel is scheduled for May 14, 2026. The filing contains a severe warning that delisting would materially limit the company's ability to raise capital, potentially leading to restructuring and a total loss for stockholders. This indicates a critical financial and operational situation, with the proposed reverse split being a last-ditch effort to maintain listing and access to capital markets. Investors should be aware of the significant risks highlighted by the company itself.

At the time of this filing, XAIR was trading at $0.52 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.4M. The 52-week trading range was $0.43 to $5.84. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XAIR - Latest Insights

XAIR
Jul 09, 2026, 9:20 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.4301
Real-time Price: $5.37 info
Change: Reverse Stock Split info
Market Cap: $3.866M info
XAIR
Jun 26, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.481
Real-time Price: $5.37 info
Change: Reverse Stock Split info
Market Cap: $3.866M info
XAIR
Jun 26, 2026, 4:15 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.481
Real-time Price: $5.37 info
Change: Reverse Stock Split info
Market Cap: $3.866M info
XAIR
Jun 26, 2026, 4:06 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.495
Real-time Price: $5.37 info
Change: Reverse Stock Split info
Market Cap: $3.866M info
XAIR
Jun 26, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.5499
Real-time Price: $5.37 info
Change: Reverse Stock Split info
Market Cap: $3.866M info